Viewing StudyNCT05656222



Ignite Creation Date: 2024-05-06 @ 6:25 PM
Last Modification Date: 2024-10-26 @ 2:47 PM
Study NCT ID: NCT05656222
Status: WITHDRAWN
Last Update Posted: 2023-02-16
First Post: 2022-12-09

Brief Title: Irinotecan and Anlotinib for Epithelioid Sarcoma
Sponsor: Peking University Peoples Hospital
Organization: Peking University Peoples Hospital

Conditions & Keywords Data

Conditions:
Name
Objective Response
Overall Survival
Keywords:
Name View
Epithelioid sarcoma View
systemic treatment View
objective response View
toxicity View